• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病进展与衰弱进展之间的关系:真实临床实践中的五年观察

Relationship Between COPD Progression and Frailty Progression: A Five-year Observation in Real Clinical Practice.

作者信息

Nishimura Koichi, Kusunose Masaaki, Shibayama Ayumi, Nakayasu Kazuhito

机构信息

National Center for Geriatrics and Gerontology, Obu, Aichi, Japan.

Clinic Nishimura, Ayabe, Kyoto, Japan.

出版信息

Int J Chron Obstruct Pulmon Dis. 2025 Jun 14;20:1955-1964. doi: 10.2147/COPD.S512326. eCollection 2025.

DOI:10.2147/COPD.S512326
PMID:40534761
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12176056/
Abstract

PURPOSE

Although a cross-sectional association between frailty and chronic obstructive pulmonary disease (COPD) has been established, the longitudinal relationship between the progression of both frailty and COPD remains unclear.

MATERIALS AND METHODS

This longitudinal study followed 87 COPD patients over five years, with evaluations conducted every six months. Participants underwent pulmonary function tests and completed the Kihon Checklist, a tool widely used in Japan to assess frailty. Kihon Checklist scores range from 0 (no frailty) to 25 (severe frailty), categorizing participants as robust (0-3), pre-frail (4-7), or frail (8-25). Annual changes were analyzed using linear mixed models.

RESULTS

A significant association was observed between time and worsening frailty classification, with patients transitioning from robust to pre-frail or from pre-frail to frail (odds ratio: 1.224, = 0.004). However, the GOLD stages (GOLD 1 to GOLD 4) did not exhibit significant progression over five years. The cohort demonstrated significant declines in forced expiratory volume in one second (FEV) and increases in Kihon Checklist total scores. FEV decreased by an estimated mean of 28.6 mL per year (95% CI: 18.9-38.4, p < 0.001), while the Kihon Checklist total score increased by 0.30 annually (95% CI: 0.09-0.51, p = 0.006). Estimated FEV declined significantly from baseline after two years in the baseline frail group (p < 0.01), after 3.5 years in the pre-frail group (p < 0.01), and after four years in the robust group (p < 0.05). Although the GOLD 3+4 group showed a significant increase in Kihon Checklist total scores after 3.5 years (p < 0.05), no significant change was observed in the GOLD 1 and GOLD 2 groups.

CONCLUSION

COPD patients with frailty show a more rapid decline in FEV, indicating accelerated COPD progression. These findings suggest frailty is static and only COPD is progressing.

摘要

目的

尽管已确定衰弱与慢性阻塞性肺疾病(COPD)之间存在横断面关联,但衰弱和COPD进展之间的纵向关系仍不明确。

材料与方法

这项纵向研究对87例COPD患者进行了为期五年的随访,每六个月进行一次评估。参与者接受了肺功能测试,并完成了《基洪检查表》,这是一种在日本广泛用于评估衰弱的工具。《基洪检查表》的分数范围为0(无衰弱)至25(严重衰弱),将参与者分为强壮(0 - 3分)、衰弱前期(4 - 7分)或衰弱(8 - 25分)。使用线性混合模型分析年度变化。

结果

观察到时间与衰弱分类恶化之间存在显著关联,患者从强壮转变为衰弱前期或从衰弱前期转变为衰弱(优势比:1.224, = 0.(此处原文可能有误,推测应为p = 0.)004)。然而,全球慢性阻塞性肺疾病倡议(GOLD)分期(GOLD 1至GOLD 4)在五年内未显示出显著进展。该队列显示一秒用力呼气容积(FEV)显著下降,且《基洪检查表》总分增加。FEV估计每年平均下降28.6 mL(95%置信区间:18.9 - 38.4,p < 0.001),而《基洪检查表》总分每年增加0.30(95%置信区间:0.09 - 0.51,p = 0.006)。在基线衰弱组中,两年后FEV从基线显著下降(p < 0.01),在衰弱前期组中,3.5年后下降(p < 0.01),在强壮组中,四年后下降(p < 0.05)。尽管GOLD 3 + 4组在3.5年后《基洪检查表》总分显著增加(p < 0.05),但GOLD 1组和GOLD 2组未观察到显著变化。

结论

衰弱的COPD患者FEV下降更快,表明COPD进展加速。这些发现表明衰弱是静态的,只有COPD在进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d0a/12176056/1b20ee5dbcfc/COPD-20-1955-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d0a/12176056/330f3227e13a/COPD-20-1955-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d0a/12176056/c2e8cfdb9028/COPD-20-1955-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d0a/12176056/4d4c41abb660/COPD-20-1955-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d0a/12176056/3a51a4b29575/COPD-20-1955-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d0a/12176056/9ce1c6bb5c54/COPD-20-1955-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d0a/12176056/1b20ee5dbcfc/COPD-20-1955-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d0a/12176056/330f3227e13a/COPD-20-1955-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d0a/12176056/c2e8cfdb9028/COPD-20-1955-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d0a/12176056/4d4c41abb660/COPD-20-1955-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d0a/12176056/3a51a4b29575/COPD-20-1955-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d0a/12176056/9ce1c6bb5c54/COPD-20-1955-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d0a/12176056/1b20ee5dbcfc/COPD-20-1955-g0006.jpg

相似文献

1
Relationship Between COPD Progression and Frailty Progression: A Five-year Observation in Real Clinical Practice.慢性阻塞性肺疾病进展与衰弱进展之间的关系:真实临床实践中的五年观察
Int J Chron Obstruct Pulmon Dis. 2025 Jun 14;20:1955-1964. doi: 10.2147/COPD.S512326. eCollection 2025.
2
Association of Patient-Reported Outcome Patterns and Major Clinical Factors with Frailty in Stable COPD.稳定期慢性阻塞性肺疾病患者报告结局模式及主要临床因素与衰弱的关联
Int J Chron Obstruct Pulmon Dis. 2025 Jun 12;20:1927-1937. doi: 10.2147/COPD.S517270. eCollection 2025.
3
Effect of deterioration of swallowing functions on the frailty status in older adults: a longitudinal cohort study.吞咽功能恶化对老年人衰弱状态的影响:一项纵向队列研究。
BMC Geriatr. 2025 Jun 24;25(1):429. doi: 10.1186/s12877-025-05896-8.
4
Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD).溴化乌美溴铵对比安慰剂用于慢性阻塞性肺疾病(COPD)患者。
Cochrane Database Syst Rev. 2017 Jun 20;6(6):CD011897. doi: 10.1002/14651858.CD011897.pub2.
5
Computer and mobile technology interventions for self-management in chronic obstructive pulmonary disease.用于慢性阻塞性肺疾病自我管理的计算机和移动技术干预措施。
Cochrane Database Syst Rev. 2017 May 23;5(5):CD011425. doi: 10.1002/14651858.CD011425.pub2.
6
Efficacy and safety of ensifentrine in treatment of COPD: a systematic review and meta-analysis of clinical trials.恩昔芬净治疗慢性阻塞性肺疾病的疗效与安全性:一项临床试验的系统评价和荟萃分析
Ther Adv Respir Dis. 2025 Jan-Dec;19:17534666251347775. doi: 10.1177/17534666251347775. Epub 2025 Jun 20.
7
Bronchoscopic lung volume reduction procedures for chronic obstructive pulmonary disease.用于慢性阻塞性肺疾病的支气管镜下肺减容术
Cochrane Database Syst Rev. 2017 Feb 23;2(2):CD012158. doi: 10.1002/14651858.CD012158.pub2.
8
Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta-analysis.慢性阻塞性肺疾病成人患者的预防性抗生素治疗:一项网络荟萃分析。
Cochrane Database Syst Rev. 2021 Jan 15;1(1):CD013198. doi: 10.1002/14651858.CD013198.pub2.
9
Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease.噻托溴铵与长效β受体激动剂治疗稳定期慢性阻塞性肺疾病的比较
Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD009157. doi: 10.1002/14651858.CD009157.pub2.
10
Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease.用于慢性阻塞性肺疾病的磷酸二酯酶4抑制剂
Cochrane Database Syst Rev. 2017 Sep 19;9(9):CD002309. doi: 10.1002/14651858.CD002309.pub5.

本文引用的文献

1
Exploring the Causal Relationship Between Frailty and Chronic Obstructive Pulmonary Disease: Insights From Bidirectional Mendelian Randomization and Mediation Analysis.探索衰弱与慢性阻塞性肺疾病之间的因果关系:来自双向孟德尔随机化和中介分析的见解
Int J Chron Obstruct Pulmon Dis. 2025 Jan 25;20:193-205. doi: 10.2147/COPD.S501635. eCollection 2025.
2
Association between chronic respiratory diseases and frailty in Chinese elderly: a population-based longitudinal study.中国老年人慢性呼吸道疾病与衰弱之间的关联:一项基于人群的纵向研究。
BMJ Open Respir Res. 2025 Jan 2;12(1):e002171. doi: 10.1136/bmjresp-2023-002171.
3
Frailty and Exacerbation of Chronic Obstructive Pulmonary Disease: Is There Any Association?
衰弱与慢性阻塞性肺疾病恶化:二者有关联吗?
Int J Chron Obstruct Pulmon Dis. 2024 May 24;19:1131-1139. doi: 10.2147/COPD.S455316. eCollection 2024.
4
Is Frailty a Mortality Predictor in Subjects with Chronic Obstructive Pulmonary Disease?衰弱是慢性阻塞性肺疾病患者的死亡预测因子吗?
Int J Chron Obstruct Pulmon Dis. 2023 Dec 11;18:2955-2960. doi: 10.2147/COPD.S439966. eCollection 2023.
5
Preserved Ratio Impaired Spirometry and COPD Accelerate Frailty Progression: Evidence From a Prospective Cohort Study.肺功能保存率受损、肺功能测定异常及慢性阻塞性肺疾病加速衰弱进展:一项前瞻性队列研究的证据
Chest. 2024 Mar;165(3):573-582. doi: 10.1016/j.chest.2023.07.020. Epub 2023 Jul 26.
6
Prevalence and risk factors of frailty in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis.慢性阻塞性肺疾病患者衰弱的患病率和危险因素:系统评价和荟萃分析。
Eur Geriatr Med. 2023 Aug;14(4):789-802. doi: 10.1007/s41999-023-00800-2. Epub 2023 Jul 12.
7
Rehabilitation for People with Respiratory Disease and Frailty: An Official American Thoracic Society Workshop Report.呼吸疾病与虚弱人群的康复:美国胸科学会官方工作坊报告
Ann Am Thorac Soc. 2023 Jun;20(6):767-780. doi: 10.1513/AnnalsATS.202302-129ST.
8
Determining factors that maintain physical function or increase frailty using the Kihon checklist among community-dwelling older adults: a six-year longitudinal study in Agano, Japan.使用《健康检查表》确定维持身体功能或延缓衰弱的因素:日本上野的一项为期六年的纵向研究。
BMC Geriatr. 2023 May 30;23(1):336. doi: 10.1186/s12877-023-04055-1.
9
Prevalence and clinical impact of frailty in COPD: a systematic review and meta-analysis.COPD 患者衰弱的患病率和临床影响:系统评价和荟萃分析。
BMC Pulm Med. 2023 May 12;23(1):164. doi: 10.1186/s12890-023-02454-z.
10
Frailty and Mortality Risk in COPD: A Cohort Study Comparing the Fried Frailty Phenotype and Short Physical Performance Battery.COPD 患者的虚弱与死亡风险:比较 Fried 虚弱表型和简短体能测试的队列研究。
Int J Chron Obstruct Pulmon Dis. 2023 Jan 20;18:57-67. doi: 10.2147/COPD.S375142. eCollection 2023.